[go: up one dir, main page]

IT8348653A0 - PHARMACEUTICAL SITION WHICH CONTAINS HETEROCYCLIC THIADIAZOLE DERIVATIVES, AND THE PROCEDURE FOR PREPARING AND COMPOSING THEM - Google Patents

PHARMACEUTICAL SITION WHICH CONTAINS HETEROCYCLIC THIADIAZOLE DERIVATIVES, AND THE PROCEDURE FOR PREPARING AND COMPOSING THEM

Info

Publication number
IT8348653A0
IT8348653A0 IT8348653A IT4865383A IT8348653A0 IT 8348653 A0 IT8348653 A0 IT 8348653A0 IT 8348653 A IT8348653 A IT 8348653A IT 4865383 A IT4865383 A IT 4865383A IT 8348653 A0 IT8348653 A0 IT 8348653A0
Authority
IT
Italy
Prior art keywords
sition
composing
pharmaceutical
preparing
procedure
Prior art date
Application number
IT8348653A
Other languages
Italian (it)
Inventor
Price Barry John
Hayes Roger
Bays David Edmund
E Macfarlane Mackinnonj Wilson
Original Assignee
Giaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giaxo Group Ltd filed Critical Giaxo Group Ltd
Publication of IT8348653A0 publication Critical patent/IT8348653A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
IT8348653A 1982-07-08 1983-07-08 PHARMACEUTICAL SITION WHICH CONTAINS HETEROCYCLIC THIADIAZOLE DERIVATIVES, AND THE PROCEDURE FOR PREPARING AND COMPOSING THEM IT8348653A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8219746 1982-07-08

Publications (1)

Publication Number Publication Date
IT8348653A0 true IT8348653A0 (en) 1983-07-08

Family

ID=10531541

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8348653A IT8348653A0 (en) 1982-07-08 1983-07-08 PHARMACEUTICAL SITION WHICH CONTAINS HETEROCYCLIC THIADIAZOLE DERIVATIVES, AND THE PROCEDURE FOR PREPARING AND COMPOSING THEM

Country Status (11)

Country Link
JP (1) JPS5927880A (en)
AU (1) AU1666583A (en)
BE (1) BE897247A (en)
DE (1) DE3324771A1 (en)
DK (1) DK317283A (en)
FR (1) FR2532937A1 (en)
GB (1) GB2124622A (en)
IT (1) IT8348653A0 (en)
NL (1) NL8302450A (en)
SE (1) SE8303913L (en)
ZA (1) ZA835009B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567191A (en) * 1983-06-07 1986-01-28 Merck & Co., Inc. Amino-phenyl-thiadiazoledioxides as gastric secretion inhibitors
DE3326545A1 (en) * 1983-07-22 1985-01-31 Ludwig Heumann & Co GmbH, 8500 Nürnberg PROPAN-2-OL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
DE3408327A1 (en) * 1984-03-07 1985-09-12 Ludwig Heumann & Co GmbH, 8500 Nürnberg DIAMOND DERIVATIVES, METHOD FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
US20040186142A1 (en) 2002-10-09 2004-09-23 Schering Corporation Pharmacopeia, Inc. Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine receptor ligands
EP1694659B8 (en) 2003-12-19 2008-10-08 Schering Corporation Thiadiazoles as cxc- and cc- chemokine receptor ligands
US7671212B2 (en) 2003-12-22 2010-03-02 Schering Corporation Isothiazole dioxides as CXC- and CC-chemokine receptor ligands
MX2008000366A (en) 2005-06-29 2008-03-07 Schering Corp Di-substituted oxadiazoles as cxc-chemokine receptor ligands.
CN101253180B (en) 2005-06-29 2011-08-03 先灵公司 5,6-Disubstituted *oxadiazopyrazines and thiadiazopyrazines as CXC-chemokine receptor ligands
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040696B1 (en) * 1980-04-30 1986-08-27 Merck & Co. Inc. Aminothiadiazoles as gastric secretion inhibitors
US4411899A (en) * 1981-12-21 1983-10-25 Merck & Co., Inc. Substituted derivatives of amino alkane diols as gastric secretion inhibitors

Also Published As

Publication number Publication date
GB2124622A (en) 1984-02-22
JPS5927880A (en) 1984-02-14
SE8303913L (en) 1984-01-09
DK317283A (en) 1984-01-09
ZA835009B (en) 1985-02-27
NL8302450A (en) 1984-02-01
DE3324771A1 (en) 1984-01-12
FR2532937A1 (en) 1984-03-16
AU1666583A (en) 1984-01-12
SE8303913D0 (en) 1983-07-08
GB8318525D0 (en) 1983-08-10
DK317283D0 (en) 1983-07-08
BE897247A (en) 1984-01-09

Similar Documents

Publication Publication Date Title
IT8348422A0 (en) HETEROCYCLIC COMPOUNDS, PROCEDURE FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
IT8547600A0 (en) THEY CONTAIN HETEROCYCLIC TETRAHYDROCARBOZOLON COMPOUNDS, PROCEDURES FOR PREPARING THEM AND PHARMACUETIC COMPOSITIONS WHICH
NO831341L (en) LABOR BONE COMPONENT FOR COURTURES.
DK89783D0 (en) PROCEDURE FOR PREPARING 3-KETO-DELTA4,9-19-NOR-STEROID DERIVATIVES
ES532007A0 (en) PROCEDURE FOR PREPARING PROLINE DERIVATIVES.
IT8248157A0 (en) SUBSTITUTED ARYL-CYCLOBUTYL-AMINE COMPOUNDS, PROCEDURES FOR PREPARING THEM, INTERMEDIATE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
ES527776A0 (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 1,4-DIHIDROPIRIDINAS.
IT8548435A0 (en) INDOL DERIVATIVE, PHARMACEUTICAL COMPOSITION THAT CONTAINS IT AND PROCEDURE FOR PREPARING IT
DK163431C (en) ANALOGY PROCEDURE FOR PREPARING 4-PHENYL-1,3-DIOXAN-CIS-5-YLALKEN OR ALKANIC ACID DERIVATIVES
ES530345A0 (en) PROCEDURE FOR PREPARING IMIDAZOLINES.
MX162676A (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 2- (PIRIDILALQUENSULFINII.) BENZIMIDAZOLES N-SUBSTITUTED
IT8149085A0 (en) INDOLIC HETEROCYCLIC COMPOUNDS, PROCEDURE FOR PRODUCING THEM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
DK405681A (en) HOLE SURGICAL SINGLE NECK, REDON-TYPE PRESENT
IT8348155A0 (en) BENZOAZACICLOALKYLSPIRO-IMIDAZOLIDINES, PROCEDURE FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
IT8348653A0 (en) PHARMACEUTICAL SITION WHICH CONTAINS HETEROCYCLIC THIADIAZOLE DERIVATIVES, AND THE PROCEDURE FOR PREPARING AND COMPOSING THEM
ES538649A0 (en) PROCEDURE FOR PREPARING PHARMACOLOGICALLY ACTIVE THIOPYRANOPYRIMIDINE COMPOUNDS.
ES527945A0 (en) PROCEDURE FOR PREPARING BENCILCARBAMOILPIRIDINE DERIVATIVES.
ES533618A0 (en) PROCEDURE FOR THE PREPARATION OF NEW GUARNINA DERIVATIVES.
DK165983C (en) PROCEDURE FOR THE PREPARATION OF PHOSPHORUS ANTIBIOTIC COMPOUNDS DESIGNED CL 1565-A, CL 1565-B AND CL 1565-T OR PHARMACEUTICAL ACCEPTABLE SALTS THEREOF
ES519477A0 (en) PROCEDURE FOR THE OBTAINING OF N- (BENZOTIOFENMETIL) -N-METHYL-HET-2-EN-4-IN-AMINE DERIVATIVES.
ES537959A0 (en) PROCEDURE FOR PREPARING IMIDAZOL DERIVATIVES.
IT8049684A0 (en) CEPHALOSPORIN COMPOUNDS, PROCEDURE FOR PREPARING THEM AND COMPOSITIONS THAT CONTAIN THEM
IT8748207A0 (en) HETEROCYCLIC COMPOUNDS THAT ACT ON 5-HYDROXYTRIPTAMINE RECEPTORS COMPOSITIONS THAT CONTAIN THEM AND PROCEDURE FOR PREPARING THEM
ES494310A0 (en) PROCEDURE FOR PREPARING 3-CYCLLOALKYLSULPHONYLPI-RROLIDINE-2,5-DIONIC 1-SUBSTITUTED DERIVATIVES
FI844374A7 (en) Process for the preparation of pharmaceutically active heterocyclic compounds.